213 related articles for article (PubMed ID: 9187694)
1. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program.
Rietbergen JB; Kruger AE; Kranse R; Schröder FH
Urology; 1997 Jun; 49(6):875-80. PubMed ID: 9187694
[TBL] [Abstract][Full Text] [Related]
2. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program.
Raaijmakers R; Kirkels WJ; Roobol MJ; Wildhagen MF; Schrder FH
Urology; 2002 Nov; 60(5):826-30. PubMed ID: 12429309
[TBL] [Abstract][Full Text] [Related]
3. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
[TBL] [Abstract][Full Text] [Related]
4. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.
Djavan B; Waldert M; Zlotta A; Dobronski P; Seitz C; Remzi M; Borkowski A; Schulman C; Marberger M
J Urol; 2001 Sep; 166(3):856-60. PubMed ID: 11490233
[TBL] [Abstract][Full Text] [Related]
5. [Ultrasound-guided biopsy: screening of prostate cancer with a single set of 14 systematic biopsies].
Perdonà S; De Sio M; Damiano R; Oliva A; D'Armiento M
Arch Ital Urol Androl; 2000 Dec; 72(4):258-63. PubMed ID: 11221051
[TBL] [Abstract][Full Text] [Related]
6. Morbidity of transrectal ultrasound-guided prostate needle biopsy in patients receiving immunosuppression.
Wammack R; Djavan B; Remzi M; Susani M; Marberger M
Urology; 2001 Dec; 58(6):1004-7. PubMed ID: 11744477
[TBL] [Abstract][Full Text] [Related]
7. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and discomfort of ten-core biopsy of the prostate evaluated by questionnaire.
Manseck A; Guhr K; Froehner M; Hakenberg OW; Wirth MP
Urol Int; 2001; 66(4):197-200. PubMed ID: 11385305
[TBL] [Abstract][Full Text] [Related]
9. [Ultrasonography-guided transrectal prostatic biopsy: indications, methods, complications. Our experience].
Borsa R; Moiso A; Fontana G
Arch Ital Urol Androl; 2002 Dec; 74(4):290-1. PubMed ID: 12508754
[TBL] [Abstract][Full Text] [Related]
10. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
[TBL] [Abstract][Full Text] [Related]
11. [Importance of repeat laterally directed sextant prostate biopsy for detection of prostate cancer in high-risk patients].
Vaiciūnas K; Auskalnis S; Matjosaitis A; Mickevicius A; Mickevicius R; Trumbeckas D; Jievaltas M
Medicina (Kaunas); 2007; 43(11):843-9. PubMed ID: 18084140
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
[TBL] [Abstract][Full Text] [Related]
13. Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated.
Terris MK; Pham TQ; Issa MM; Kabalin JN
J Urol; 1997 Jan; 157(1):204-6. PubMed ID: 8976251
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions.
Hoedemaeker RF; Kranse R; Rietbergen JB; Kruger AE; Schröder FH; van der Kwast TH
Cancer; 1999 Jan; 85(1):145-52. PubMed ID: 9921986
[TBL] [Abstract][Full Text] [Related]
15. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer.
Levine MA; Ittman M; Melamed J; Lepor H
J Urol; 1998 Feb; 159(2):471-5; discussion 475-6. PubMed ID: 9649265
[TBL] [Abstract][Full Text] [Related]
16. No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam).
Roobol MJ; van der Cruijsen IW; Schröder FH
Urology; 2004 May; 63(5):892-7; discussion 897-9. PubMed ID: 15134973
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen.
Lodding P; Aus G; Bergdahl S; Frösing R; Lilja H; Pihl CG; Hugosson J
J Urol; 1998 Mar; 159(3):899-903. PubMed ID: 9474178
[TBL] [Abstract][Full Text] [Related]
18. Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
Chiu PK; Alberts AR; Venderbos LDF; Bangma CH; Roobol MJ
BJU Int; 2017 Sep; 120(3):394-400. PubMed ID: 28498624
[TBL] [Abstract][Full Text] [Related]
19. The role of TRUS-guided biopsies for determination of internal and external spread of prostate cancer.
Lee F; Bahn DK; Siders DB; Greene C
Semin Urol Oncol; 1998 Aug; 16(3):129-36. PubMed ID: 9741417
[TBL] [Abstract][Full Text] [Related]
20. Complications and risk factors in transrectal ultrasound-guided prostate biopsies.
de Jesus CM; Corrêa LA; Padovani CR
Sao Paulo Med J; 2006 Jul; 124(4):198-202. PubMed ID: 17086300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
